GPC-75297-18743
2 vaccinations
1 coded response
9 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 068 / CT
- Registered
- 2021-08-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-12
Dose 1 — Pfizer-BioNTech
-
2021-08-02
Dose 2 — Pfizer-BioNTech
-
2021-08-13
Registered in v-safe
- 2021-08-13
- 2021-08-16
- 2021-08-23
- 2021-08-30
- 2021-09-06
- 2021-09-13
- 2021-11-01
- 2022-01-31
-
2022-08-04
Survey response — 12 months, dose 2MedDRA: Anosmia, Fatigue, Myalgia, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had Covid-19 symptoms for a few days - congestion, fatigue, muscle aches, and loss of smell - all of which resolved.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-12 | Pfizer-BioNTech | No |
| 2 | 2021-08-02 | Pfizer-BioNTech | No |
Free text
Release 12 — 12 months, dose 2
Symptoms: Had Covid-19 symptoms for a few days - congestion, fatigue, muscle aches, and loss of smell - all of which resolved.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release